Stay updated on NEO-TIM Clinical Trial: Combo in Resectable Melanoma

Sign up to get notified when there's something new on the NEO-TIM Clinical Trial: Combo in Resectable Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the NEO-TIM Clinical Trial: Combo in Resectable Melanoma page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T15:46:48.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-26T14:28:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website footer now identifies the platform as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T14:16:04.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:28:19.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study record history now shows a new revision, changing from v3.6.6 to v3.7.0. This indicates a software or interface update to the page.
    Difference
    0.1%
    Check dated 2026-09-21T20:38:05.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history while the previous v3.6.5 entry was removed, reflecting a recent update to the history display.
    Difference
    0.1%
    Check dated 2026-08-31T17:43:03.000Z thumbnail image

Stay in the know with updates to NEO-TIM Clinical Trial: Combo in Resectable Melanoma

Enter your email address, and we'll notify you when there's something new on the NEO-TIM Clinical Trial: Combo in Resectable Melanoma page.